logo

Paratek Pharmaceuticals, Inc. (PRTK)



Trade PRTK now with
  Date
  Headline
5/9/2019 9:39:42 AM Wedbush Is Lowering Paratek Pharmaceuticals, Inc. (PRTK) Q4 19 Rev. Estimate To 3.6 M From 4.9 M
5/9/2019 9:39:31 AM Wedbush Is Cutting Paratek Pharmaceuticals, Inc. (PRTK) Q3 19 Rev. Estimate To 2.8 M From 3.7 M
5/9/2019 9:39:11 AM Wedbush Is Lowering Paratek Pharmaceuticals, Inc. (PRTK) Q2 19 Rev. Estimate To 1.9 M From 2.7 M
5/9/2019 9:38:48 AM Wedbush Is Increasing Paratek Pharmaceuticals, Inc. (PRTK) FY19 Estimate To -4.58 From -4.72
5/9/2019 9:38:36 AM Wedbush Is Raising Paratek Pharmaceuticals, Inc. (PRTK) Q4 19 Estimate To -1.17 From -1.19
5/9/2019 9:38:25 AM Wedbush Is Raising Paratek Pharmaceuticals, Inc. (PRTK) Q3 19 Estimate To -1.16 From -1.18
5/9/2019 9:38:13 AM Wedbush Is Increasing Paratek Pharmaceuticals, Inc. (PRTK) Q2 19 Estimate To -1.15 From -1.16
4/4/2019 8:36:15 AM Paratek Pharma Presents New Data From NUZYRA Development Program At ECCMID 2019
3/18/2019 8:08:45 AM Paratek Pharma CFO Douglas Pagán To Resign, Effective April 5
11/27/2018 8:11:36 AM Paratek Doses First Patient In Phase 2 Trial Of Omadacycline In Acute Pyelonephritis
10/2/2018 8:47:30 AM Paratek Pharma: FDA Approves SEYSARA For Moderate To Severe Acne
10/1/2018 4:04:08 PM Paratek Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
8/8/2018 7:07:16 AM Paratek Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee To Review Omadacycline NDA
8/3/2018 8:53:13 AM Wedbush Is Cutting Paratek Pharmaceuticals, Inc. (PRTK) FY19 Rev. Estimate To 36.5 M From 43.9 M
8/3/2018 8:53:01 AM Wedbush Is Increasing Paratek Pharmaceuticals, Inc. (PRTK) FY18 Rev. Estimate To 12.1 M From 12.0 M
8/3/2018 8:52:41 AM Wedbush Is Lowering Paratek Pharmaceuticals, Inc. (PRTK) FY19 Estimate To -3.66 From -3.53
8/3/2018 8:52:30 AM Wedbush Is Lowering Paratek Pharmaceuticals, Inc. (PRTK) FY18 Estimate To -3.42 From -3.37
  
 
>